| 1 |
Clinicopathological Predictors of Recurrence in High-Risk Basal Cell Carcinoma Patients, A Retrospective Analysis |
2026 |
| 2 |
Diagnostic potential of serum humanin in breast cancer among the Egyptian population |
2026 |
| 3 |
Platinum-based vs non-platinum based chemotherapy in metastatic triple negative breast cancer : A retrospective study |
2026 |
| 4 |
Predictive value of METTL3 in metastatic colorectal cancer treated with irinotecan |
2026 |
| 5 |
The prognostic and predictive value of METTL3 in Metastatic Colorectal cancer |
2026 |
| 6 |
The prognostic role of serum human epidermal growth factor receptor (HER2) in metastatic breast cancer patients |
2026 |
| 7 |
Epidemiological and Clinicopathological Data on Metastatic Colorectal Cancer at South Egypt Cancer Institute (SECI) |
2025 |
| 8 |
Evaluation of the relationship between H. Pylori-infected gastric mucosa and prognosis of gastrointestinal stromal tumor |
2025 |
| 9 |
Gefitinib in Non-Small Cell Lung Cancer: A Prospective Study at South Egypt Cancer Institute |
2025 |
| 10 |
Klotho and LRP6 as Emerging Biomarkers in Gastric Adenocarcinoma: Expression Patterns and Clinical Relevance |
2025 |